Email Page Print Page

SEC Filings and Financial Information

Select the filing type and date range you wish to view from the drop-down menus below.

NASDAQBDSI
FormDescriptionDateFormat
DEFA14AAdditional proxy soliciting materials - definitiveNov 22, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventNov 17, 2017View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesNov 17, 2017View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventNov 13, 2017View HTMLDownload DOCDownload PDFDownload XLS
10-QQuarterly report which provides a continuing view of a company's financial positionNov 9, 2017View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
DEF 14AOfficial notification to shareholders of matters to be brought to a vote ("Proxy")Nov 1, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventOct 12, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventOct 6, 2017View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesSep 22, 2017View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventSep 12, 2017View HTMLDownload DOCDownload PDFDownload XLS
CT ORDERConfidential treatment orderSep 5, 2017View HTMLDownload DOCDownload PDF
8-K/AAmendment to a previously filed 8-KSep 1, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventAug 29, 2017View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesAug 16, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 16, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 16, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 16, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 16, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 16, 2017View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventAug 10, 2017View HTMLDownload DOCDownload PDFDownload XLS
10-QQuarterly report which provides a continuing view of a company's financial positionAug 9, 2017View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
8-KReport of unscheduled material events or corporate eventAug 1, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventJul 18, 2017View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJul 18, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 18, 2017View HTMLDownload DOCDownload PDF
1-25      26-50      51-63
Top News
Nov 16, 2017

BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a specialty pharmaceutical company with a focus in pain management and addiction medicine, today announced that Dr. Mark A. Sirgo, Vice...

Nov 9, 2017

BioDelivery Sciences International, Inc. (BDSI) today reported financial results for the three and nine months ended September 30, 2017, and provided an update on recent business highlights and...

Oct 30, 2017

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it will report its third quarter 2017 financial results and host a conference call and webcast at 4:30 PM Eastern Time on...

investor inquiries

 

Al Medwar
Senior Vice President, Corporate and Business Development
BioDelivery Sciences International, Inc.
919-582-9050
amedwar@bdsi.com